Abstract
Currently the most widely used treatment in patients with Duchenne muscular dystrophy (DMD) is the administration of corticosteroids, but prolonged use produces several serious side effects. Thus, it is critical to search for alternative therapies that minimize disease progression and improve quality of life of dystrophic patients with fewer side effects than corticosteroids. Since oxidat…